AU6683400A - Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat - Google Patents

Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat

Info

Publication number
AU6683400A
AU6683400A AU66834/00A AU6683400A AU6683400A AU 6683400 A AU6683400 A AU 6683400A AU 66834/00 A AU66834/00 A AU 66834/00A AU 6683400 A AU6683400 A AU 6683400A AU 6683400 A AU6683400 A AU 6683400A
Authority
AU
Australia
Prior art keywords
vaccine
immune deficiency
deficiency virus
cat
vaccine against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU66834/00A
Inventor
Christian Leutenegger
Hans Lutz
Matthias Schroff
Burghardt Wittig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MOLOGEN FORSCHUNGS- ENTWICKLUNGS- und VERTRIEBS GmbH
Universitaet Zuerich
Original Assignee
MOLOGEN FORSCHUNGS ENTWICKLUNG
Universitaet Zuerich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MOLOGEN FORSCHUNGS ENTWICKLUNG, Universitaet Zuerich filed Critical MOLOGEN FORSCHUNGS ENTWICKLUNG
Publication of AU6683400A publication Critical patent/AU6683400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

The invention relates to a vaccine which is capable of inducing protection against disease as a result of a lentiviral infection, in particular, infection with the feline immune deficiency virus (FIV). The vaccination can be carried out in such a way, that inoculated animals can be differentiated from diseased or infected animals by the status of their antibodies. A vaccine of this type contains a DNA sequence which contains the envelope glycoprotein and preferably a part of the gene that codes for the transmembrane protein. The invention is also characterised in that suitable adjuvants are added to the vaccine mixture which elicit a cytotoxic immune response, for example cytokine of the TH1 response, cytokine coding DNA expression constructions, or immune-stimulatory DNA sequences.
AU66834/00A 1999-07-08 2000-07-08 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat Abandoned AU6683400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1258/1999 1999-07-08
CH125899 1999-07-08
PCT/DE2000/002262 WO2001004280A2 (en) 1999-07-08 2000-07-08 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat

Publications (1)

Publication Number Publication Date
AU6683400A true AU6683400A (en) 2001-01-30

Family

ID=4206186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU66834/00A Abandoned AU6683400A (en) 1999-07-08 2000-07-08 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat

Country Status (5)

Country Link
EP (1) EP1203078B1 (en)
AT (1) ATE294857T1 (en)
AU (1) AU6683400A (en)
DE (1) DE50010240D1 (en)
WO (1) WO2001004280A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0118367D0 (en) * 2001-07-27 2001-09-19 Glaxosmithkline Biolog Sa Novel use
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
WO2006011919A1 (en) 2004-06-30 2006-02-02 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
US7201903B2 (en) 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1709447B1 (en) 2003-12-18 2009-06-24 Idexx Laboratories, Inc. Method for detecting feline immunodeficiency virus
EP1723425B1 (en) 2004-02-19 2011-04-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
JP4662988B2 (en) * 2004-06-30 2011-03-30 アイデックス ラボラトリーズ インコーポレイテッド Method and apparatus for detecting feline immunodeficiency virus
CA2576930C (en) 2004-06-30 2011-06-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
WO2011123781A1 (en) 2010-04-02 2011-10-06 Idexx Laboratories, Inc. Detection of feline immunodeficiency virus
GB201013153D0 (en) 2010-08-04 2010-09-22 Touchlight Genetics Ltd Primer for production of closed linear DNA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219936D0 (en) * 1992-09-21 1992-11-04 Pitman Moore Inc Vaccines
US5571515A (en) * 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
EP0758396B1 (en) * 1994-04-29 2006-07-26 Pharmacia & Upjohn Company LLC Feline immunodeficiency virus vaccine
FR2751223B1 (en) * 1996-07-19 1998-12-04 Rhone Merieux FELIN POLYNUCLEOTIDE VACCINE FORMULA

Also Published As

Publication number Publication date
ATE294857T1 (en) 2005-05-15
WO2001004280A2 (en) 2001-01-18
EP1203078A2 (en) 2002-05-08
DE50010240D1 (en) 2005-06-09
WO2001004280A3 (en) 2001-07-05
EP1203078B1 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
Hanlon et al. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors
CO4750842A1 (en) POX RECOMBINANT VACCINES OF MAPACHE AND VACCINE EFFECTIVE AGAINST INFECTION OF FELINE IMMUNODEFICIENCY VIRUSES.
ATE144143T1 (en) ARTIFICIAL VACCINE AGAINST AIDS VIRUS
KR900700508A (en) Chimeric glycoprotein containing glycoprotein immune fragments against human respiratory syncytial virus
EP1728863A3 (en) C-class oligonucleotide analogs with enhanced immunostimulatory potency
CZ15999A3 (en) Formulation of polynucleotide vaccine of cats
CY1110359T1 (en) CIRCULAR SWINE-based vaccine
WO2002022686A3 (en) Defensin-antigen fusion proteins
RU2008102930A (en) METHODS FOR ADMINISTRATION OF VACCINES, NEW CALICIVIRUSES OF CAT AND TREATMENT OPTIONS FOR IMMUNIZATION OF ANIMALS AGAINST CATVARVOIRUS OF CAT AND VIRTUAL VIRGIN OF CAT
AU6683400A (en) Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat
Oswald et al. Interleukin-12 synthesis is a required step in trehalose dimycolate-induced activation of mouse peritoneal macrophages
BR0206823A (en) Chimeric gene, chimeric protein, recombinant virus, vaccine composition, use of a vaccine composition, therapeutic or preventive combination, and plasmid
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ES2298829T3 (en) AGENT FOR THE TREATMENT OF INFECTIONS BY LEISHMANIA.
Tudor et al. Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C
EP2950816B1 (en) The use of dna sequences encoding an interferon as vaccine adjuvants
WO2002022687A3 (en) Viral chemokine-tumur antigen fusion proteins
Hsieh et al. The effect of co-administration of DNA carrying chicken interferon-γ gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
O’Donovan et al. A vector expressing feline mature IL-18 fused to IL-1β antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus
ZA941853B (en) Stimulation of immune response by viral protein
AU2003281917A8 (en) Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats
WO2003025002A3 (en) Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
Okuda et al. Cytokine and costimulatory factor-encoding plasmids as adjuvants for DNA vaccination
DE60236943D1 (en) INDUCED IMMUNE RESPONSE AGAINST THE CAT IMMUNE WEAKEN VIRUS

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase